Literature DB >> 30907290

Actors in whitespace: Communicating risk information on pharmaceutical websites.

Amie C O'Donoghue1, Helen W Sullivan1, Douglas J Rupert2, Jessica Fitts Willoughby2, Kathryn J Aikin1.   

Abstract

This study examined the use of an actor to communicate prescription drug risks on pharmaceutical websites. Participants viewed risk information for a fictitious drug in one of several static visual formats or as a paragraph plus an animated actor; and with or without a signal directing them to the risk information text. The signal had little effect on outcomes. Format did not affect risk processing, but participants in the actor condition thought the website placed less emphasis on benefits. Actors communicating risk information on a pharmaceutical website do not appear to improve consumers' understanding of prescription drug information.

Entities:  

Keywords:  Animation; direct-to-consumer promotion; online video; prescription drugs; risk communication

Mesh:

Substances:

Year:  2019        PMID: 30907290      PMCID: PMC7358773          DOI: 10.1080/07359683.2019.1575063

Source DB:  PubMed          Journal:  Health Mark Q        ISSN: 0735-9683


  8 in total

1.  Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.

Authors:  Hyosun Kim
Journal:  Int J Health Policy Manag       Date:  2015-08-25

2.  Is the information "fair and balanced" in direct-to-consumer prescription drug websites?

Authors:  Jisu Huh; Brenda J Cude
Journal:  J Health Commun       Date:  2004 Nov-Dec

3.  Consumer perceptions of prescription drug websites: a pilot study.

Authors:  Walter Wymer
Journal:  Health Mark Q       Date:  2010-04

4.  Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites.

Authors:  Helen W Sullivan; Amie C O'Donoghue; Douglas J Rupert; Jessica Fitts Willoughby; Kathryn J Aikin
Journal:  J Health Commun       Date:  2017-01-27

Review 5.  Informed decision making: what is its role in cancer screening?

Authors:  Barbara K Rimer; Peter A Briss; Paula K Zeller; Evelyn C Y Chan; Steven H Woolf
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

6.  Validation of screening questions for limited health literacy in a large VA outpatient population.

Authors:  Lisa D Chew; Joan M Griffin; Melissa R Partin; Siamak Noorbaloochi; Joseph P Grill; Annamay Snyder; Katharine A Bradley; Sean M Nugent; Alisha D Baines; Michelle Vanryn
Journal:  J Gen Intern Med       Date:  2008-03-12       Impact factor: 5.128

7.  Shared decision making about screening and chemoprevention. a suggested approach from the U.S. Preventive Services Task Force.

Authors:  Stacey L Sheridan; Russell P Harris; Steven H Woolf
Journal:  Am J Prev Med       Date:  2004-01       Impact factor: 5.043

8.  The rise of digital direct-to-consumer advertising?: Comparison of direct-to-consumer advertising expenditure trends from publicly available data sources and global policy implications.

Authors:  Tim K Mackey; Raphael E Cuomo; Bryan A Liang
Journal:  BMC Health Serv Res       Date:  2015-06-19       Impact factor: 2.655

  8 in total
  1 in total

1.  The FDA's Diverse and Dynamic Activities in the Social and Behavioral Sciences: Advancing and Supporting Health Equity.

Authors:  Christine Lee; Melanie J McLean; Caroline J Huang; Anh Nguyen Zarndt; Kathryn J Aikin; Paula Rausch; Barbara R Cohen; Janine Delahanty; Danielle M Sholly; Wendy I Slavit; Ewa D Carlton
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.